ArticleActas espanolas de psiquiatria2025
Cognitive Behavioral Therapy Improves the Quality of Life for Patients with Mild to Moderate Depression due to Glaucoma or Cataracts: A Retrospective Study.
Article in Actas espanolas de psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The bidirectional enigma of glaucoma and anxiety: from neuroinflammatory mechanisms to mind-body integrated therapies.Frontiers in psychiatry · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndividuals affected with glaucoma and cataracts are more likely to experience depressive symptoms, which can affect their overall quality of life (QOL) and functioning. Therefore, this retrospective cohort study aimed to evaluate the impact of cognitive behavioral therapy (CBT) on glaucoma or cataracts patients with mild to moderate depression.
methodsThis study included patients with mild to moderate depression resulting from glaucoma or cataracts in our hospital from January 2023 to December 2023. The study participants were divided into an untreated group and a cognitive behavioral therapy group based on different intervention methods. We assessed depressive symptoms using the Center for Epidemiologic Studies Depression Scale (CES-D) and Patient Health Questionnaire-9 (PHQ-9). QOL was evaluated using the Chinese translation version of the European Quality of Life-5 Dimensions scale (EQ-5D), Short Form Health Survey (SF-36), National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Additionally, cognitive behavioral therapy (CBT) was administered to a subgroup of patients with mild to moderate depression, and the impact of CBT on the well-being of the patients was analyzed.
resultsThis study included 3010 individuals, consisting of untreated patients (n = 2151) and those who received cognitive behavioral therapy (n = 859). Post-intervention analysis revealed that compared to baseline, the CES-D scores (p < 0.001), PHQ-9 scores (p < 0.001), and HADS anxiety subscale scores (p < 0.001) were significantly reduced in the CBT group. Furthermore, the CBT group demonstrated a significant increase in EQ-5D scores (p < 0.001) and SF-36 mental component scores (p < 0.001) post-intervention compared to baseline.
conclusionThese findings offer significant insights into the prospective effectiveness of CBT in improving depressive symptoms and QOL in individuals with glaucoma or cataracts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.